Name | Symbol | Markt | Aktientyp |
---|---|---|---|
NanoViricides Inc | NNVC | AMEX | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
1,13 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
16.2.2024 | 22:53 | EDGAR2 | Form 8-K - Current report |
14.2.2024 | 22:55 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
19.1.2024 | 22:44 | EDGAR2 | Form 8-K - Current report |
04.12.2023 | 22:08 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
13.10.2023 | 22:30 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
28.9.2023 | 22:44 | EDGAR2 | Form NT 10-K - Notification of inability to timely file Form.. |
01.9.2023 | 22:46 | EDGAR2 | Form 8-K - Current report |
06.7.2023 | 17:16 | IHNW | Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is.. |
04.5.2023 | 12:45 | GLOBE | NanoViricides, Inc. to Present at The Inaugural Ef Hutton.. |